We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Geoffrey Morrison Life moves pretty quickly. If you don’t have a dash cam to ...

The Fury (Part 3) in Avatar Frontiers of Pandora From The Ashes DLC is the third and final mission of The Fury quest series. You can only begin it after completing the first two parts of the questline ...

Timothée Chalamet confirmed “Dune: Part 3” will see a nearly two-decade time jump, which is why his character is sporting a new look. The actor addressed his shorter ‘do during an appearance on “The ...

You can trust VideoGamer. Our team of gaming experts spend hours testing and reviewing the latest games, to ensure you're reading the most comprehensive guide possible. Rest assured, all imagery and ...

Naoki Hamaguchi, the director on Final Fantasy VII Remake Part 3, has revealed during an interview with Julien Chieze that the core game experience for the highly anticipated final entry in the ...

GameSpot may get a commission from retail offers. What's in a name? If you're Square Enix, a lot, as the studio has yet to reveal the full title of Final Fantasy 7 Remake. That reveal could be soon, ...

Joshua grew up in poverty, deep in the Middle of Nowhere, Alabama. Gaming was a rarely afforded escape from reality that persisted throughout his life, something that saw him through good times and ...

According to a post shared by an X (formerly Twitter) fan page that regularly shares updates related to Timothée Chalamet, the leading star of Dune, production on the third part has now concluded.

Final Fantasy 7 Remake Part 3 is the next and most anticipated part of the Final Fantasy 7 game that is expected to release in Q1 of 2027. There’s still a lot of time before Part 3 launches, finishing ...

Final Fantasy 7 Remake trilogy director Naoki Hamaguchi has good news for anyone worried that its concluding act would strip out elements in response to pushback against the scale of FF7 Rebirth. The ...

Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...